Replies to post #94 on Acasti Pharma, Inc (ACST)

[oldberkeley]

Jaytea- I will be glad to.

I already have one basic question that someone here might be able to help with:

According to the company website, the COLT trial was to assess the safety and efficacy of CaPre in mild-to-severe hypertriglyceridemic patients. And the TRIFECTA trial is to assess the safety and efficacy of CaPre in mild-to-severe hypertriglyceridemic patients.

What's the difference between the two?

TIA